GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rite Aid Corp (OTCPK:RADCQ) » Definitions » Gross Profit
中文

Rite Aid (Rite Aid) Gross Profit

: $4,727 Mil (TTM As of Aug. 2023)
View and export this data going back to 1970. Start your Free Trial

Rite Aid's gross profit for the three months ended in Aug. 2023 was $1,096 Mil. Rite Aid's gross profit for the trailing twelve months (TTM) ended in Aug. 2023 was $4,727 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Rite Aid's gross profit for the three months ended in Aug. 2023 was $1,096 Mil. Rite Aid's Revenue for the three months ended in Aug. 2023 was $5,646 Mil. Therefore, Rite Aid's Gross Margin % for the quarter that ended in Aug. 2023 was 19.40%.

Rite Aid had a gross margin of 19.40% for the quarter that ended in Aug. 2023 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of Rite Aid was 28.69%. The lowest was 19.57%. And the median was 21.85%.

Warning Sign:

Rite Aid Corp gross margin has been in long-term decline. The average rate of decline per year is -2.1%.


Rite Aid Gross Profit Historical Data

The historical data trend for Rite Aid's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rite Aid Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,676.35 4,726.76 4,704.32 5,106.50 4,803.94

Rite Aid Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,154.50 1,203.75 1,248.96 1,178.53 1,095.60

Competitive Comparison

For the Pharmaceutical Retailers subindustry, Rite Aid's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rite Aid Gross Profit Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Rite Aid's Gross Profit distribution charts can be found below:

* The bar in red indicates where Rite Aid's Gross Profit falls into.



Rite Aid Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Rite Aid's Gross Profit for the fiscal year that ended in Feb. 2023 is calculated as

Gross Profit (A: Feb. 2023 )=Revenue - Cost of Goods Sold
=24091.899 - 19287.959
=4,804

Rite Aid's Gross Profit for the quarter that ended in Aug. 2023 is calculated as

Gross Profit (Q: Aug. 2023 )=Revenue - Cost of Goods Sold
=5646.081 - 4550.485
=1,096

Gross Profit for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,727 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Rite Aid's Gross Margin % for the quarter that ended in Aug. 2023 is calculated as

Gross Margin % (Q: Aug. 2023 )=Gross Profit (Q: Aug. 2023 ) / Revenue (Q: Aug. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=1,096 / 5646.081
=19.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Rite Aid  (OTCPK:RADCQ) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Rite Aid had a gross margin of 19.40% for the quarter that ended in Aug. 2023 => No sustainable competitive advantage


Rite Aid Gross Profit Related Terms

Thank you for viewing the detailed overview of Rite Aid's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Rite Aid (Rite Aid) Business Description

Traded in Other Exchanges
Address
1200 Intrepid Avenue, PO Box 3165, Philadelphia, PA, USA, 17105
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
Executives
Christopher W. Dupaul officer: Chief Operating Officer 1200 INTREPID AVENUE, 2ND FLOOR, PHILADELPHIA PA 19112
Sabatino Thomas J Jr officer: Chief Legal Officer C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
Steven Bixler officer: Chief Accounting Officer C/O RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Heyward R Donigan officer: Chief Executive Officer 452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451
Jocelyn Z Konrad officer: Executive VP RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Ray Smithberger officer: SVP, Operations 30 HUNTER LANE, CAMP HILL PA 17011
Bari A Harlam director C/O MOHAWK GROUP HOLDINGS, INC., 37 EAST 18TH STREET, 7TH FLOOR, NEW YORK NY 10003
Paul D Gilbert officer: EVP, Secretary&General Counsel 103 POWELL COURT, SUITE 200, BRENTWOOD TN 37027
Andre Persaud officer: EVP, Retail 30 HUNTER LANE, CAMP HILL PA 17011
Dan Robson officer: President, EnvisionRXOptions 30 HUNTER LANE, CAMP HILL PA 17011
James J Peters officer: Chief Operating Officer C/O NXSTAGE MEDICAL, INC., 350 MERRIMACK STREET, LAWRENCE MA 01843
James J Comitale officer: EVP, General Counsel, Secy. 30 HUNTER LANE, CAMP HILL PA 17011
Jessica Kazmaier officer: EVP, Chief HR Officer 30 HUNTER LANE, CAMP HILL PA 17011
Justin L. Mennen officer: EVP, Chief Information Officer 30 HUNTER LANE, CAMP HILL PA 17011
Katherine B Quinn director US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402